EXG-5003

· Fujita Health University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EXG-5003, covering 2023-01-26 to 2023-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of EXG-5003 [Phase 1, Phase 2]